"AI will have all the places and no place at all in game development," says Jörg Tittel, who was behind 2023's C-Smash VRS.
Kevin Harvick explains why Keelan Harvick joined Toyota Racing Development, outlining the decision behind his son’s early ...
Since then, sports data has broken the dam, with complex analytics spilling over from first down visualizations to Moneyball-era baseball, revealing a need for context that can channel the information ...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic conditions, today highlighted recent scientific ...
If watching The Pitt is giving you a renewed interest in the human body in all of its gory glory, there’s a new tool that will help satisfy your curiosity. An international team of scientists ...
An international team of scientists and clinicians has announced the launch of a new open-access 3D portal that allows users to explore intact human organs in unprecedented detail—from the whole organ ...
Current tools for assessing ischemic stroke and bleeding risks in patients with atrial fibrillation focus on warfarin users and initial therapy decisions; however, dynamic models for reassessing these ...
Babies with congenital heart disease have altered brain activity in regions involved in movement and emotions, but heart surgery restored these brain networks to healthy connectivity.
A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults with heart disease. Harnessing cellular therapies, the company aims to ...
Google Earth’ for human organs made available online An international team of scientists and clinicians has announced, in ...
Early intervention in childhood obesity can significantly reduce future health risks and promote sustainable weight management before age ten.
A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults with heart disease. Harnessing cellular therapies, the company aims to ...